MULTIDISCIPLINARY SUPPORT FOR BUPRENORPHINE-NALOXONE TREATMENT OF OPIOID USE DISORDER

被引：0
|
作者：
Hall, A. [1 ]
机构：
[1] Univ Washington, Sch Med, Seattle, WA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2020年 / 68卷
关键词：
D O I：
10.1136/jim-2019-WMRC.175
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
175
引用
收藏
页码：A75 / A75
页数：1
相关论文
共 50 条
  • [21] Buprenorphine-naloxone
    Hu, Tina
    Nijmeh, Larry
    Pyle, Adam
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (47) : E1389 - E1389
  • [22] Kratom use disorder: case reports on successful treatment with home induction of buprenorphine-naloxone
    Kiyokawa, Miki
    Kwon, Anthony K.
    Cape, Micaiah C.
    Streltzer, Jon M.
    FAMILY PRACTICE, 2023, 40 (04) : 596 - 598
  • [23] The role of Alberta pharmacists working in opioid use disorder and their potential to prescribe buprenorphine-naloxone: A qualitative study
    Olatunbosun, Caitlin
    Moharram, Mostafa
    Gottschalk, Samantha
    Biggs, Catherine
    CANADIAN PHARMACISTS JOURNAL, 2025, 158 (01) : 41 - 46
  • [24] Buprenorphine/Naloxone for the Treatment of Opioid Use Disorder in Organ Transplantation Patients
    Lynch, Marie-Josee
    Zimbrean, Paula
    AMERICAN JOURNAL ON ADDICTIONS, 2017, 26 (03): : 268 - 269
  • [25] Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence Retrospective cohort study of 30 patients
    Dooley, Joe
    Gerber-Finn, Lianne
    Antone, Irwin
    Guilfoyle, John
    Blakelock, Brittany
    Balfour-Boehm, Jazmyn
    Hopman, Wilma M.
    Jumah, Naana
    Kelly, Len
    CANADIAN FAMILY PHYSICIAN, 2016, 62 (04) : E194 - E200
  • [26] Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment
    Nunes, Edward V., Jr.
    Scodes, Jennifer M.
    Pavlicova, Martina
    Lee, Joshua D.
    Novo, Patricia
    Campbell, Aimee N. C.
    Rotrosen, John
    AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (07): : 660 - 671
  • [27] The association of Medicare Part D prior authorization for buprenorphine-naloxone with adherence to opioid use disorder treatment guidelines in the United States
    Parish, William J.
    Mark, Tami L.
    Zarkin, Gary A.
    Weber, Ellen
    ADDICTION, 2022, 117 (01) : 141 - 150
  • [28] Evaluation of opioid use disorder treatment outcomes in patients receiving split daily versus once daily dosing of buprenorphine-naloxone
    Borris, Joshua B.
    Dowd-Green, Caitlin
    Bowman, Lindsay A.
    Nesbit, Suzanne A.
    Fingerhood, Michael
    Stewart, Rosalyn W.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 156
  • [29] Is buprenorphine-naloxone ready for prime time in the treatment of opioid addiction in managed care?
    Curtiss, Frederic R.
    JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (02): : 195 - 197
  • [30] A pilot study of buprenorphine-naloxone combination tablet (Suboxone®) in treatment of opioid dependence
    Bell, J
    Byron, G
    Gibson, A
    Morris, A
    DRUG AND ALCOHOL REVIEW, 2004, 23 (03) : 311 - 317
12345